A New Eugenics Wave: Trying to Make Disability and Disease Disappear
By Elayne Clift,
Daily Kos
| 05. 01. 2025
Photo of Judy Heumann by Taylordw,
CC BY-SA 4.0, via Wikimedia Commons
Back in the 1980s when I was a budding journalist publishing articles related to women and health while working as Program Director for the National Women’s Health Network, I had the privilege of interviewing Judy Heumann and her collaborator Ed Roberts. Judy was known by then as the Mother of the Disability Movement and Ed was called the Father of Independent Living.
Judy, who died in 2023, had contracted polio as a child who then spent the rest of her life in a wheelchair. She was denied the right to attend school because she was considered a fire hazard at the age of five. That was the seed that led to her life’s work. Determined to work with other disabled people, she helped found the Berkeley Center for Independent Living and the World Institute on Disability with Ed, who also had polio at the age of fourteen. It left him completely paralyzed and on a respirator for the rest of his life. Undeterred, Ed fought to...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...